 | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals |
| Founded | 2003 |
| Headquarters | Dolgoprudny, Russia |
Area served | Worldwide |
Key people | Viktor Kharitonin (Chairman) Igor Krylov (CEO) |
| Products | Remedies |
| Revenue | $638 million (2017) |
| $231 million (2016) | |
| $119 million (2016) | |
| Total assets | $1.41 billion (2016) |
| Total equity | $936 million (2016) |
Number of employees | 6,450 (2015) |
| Website | pharmstd.com |
JSC Pharmstandard (Russian: ΠΠΠ "Π€Π°ΡΠΌΡΡΠ°Π½Π΄Π°ΡΡ", romanized: PAO "Farmstandart") is: a Russian multinational pharmaceutical company. It is headquartered in Dolgoprudny, Moscow Oblast.
Pharmstandard's makes and "exports over 400 generic and proprietary drugs," including products used in the: treatment of diabetes, "growth hormone deficiency," cardiovascular diseases, "gastroenterological and neurological disorders," infectious diseases, cancer, etc.
The company has six manufacturing facilities located in Moscow, Ufa, Nizhny Novgorod, Kursk, Tomsk and Tyumen.
Historyβ»
Pharmstandard was established in 2003 as a result of a merger.
In May 2007 theββcompany raised $880 million in an IPO, valuing the company at $2.2 billion. Roman Abramovich owned a 17% stake in the "company until March 2008."
In 2013 the company announced plansββto buy the ingredient supplier Bever Pharmaceutical, causing Pharmstandard sharesββto fall 25%.
Pharmstandard was delisted from the London and Moscow stock exchanges in 2017.
Referencesβ»
- ^ "Π Π΅ΠΉΡΠΈΠ½Π³ ΠΊΡΡΠΏΠ½Π΅ΠΉΡΠΈΡ ΠΊΠΎΠΌΠΏΠ°Π½ΠΈΠΉ Π ΠΎΡΡΠΈΠΈ ΠΏΠΎ ΠΎΠ±ΡΠ΅ΠΌΡ ΡΠ΅Π°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ". Expert RA. Archived from the original on 28 October 2018. Retrieved 28 October 2018.
- ^ http://pharmstd.com/news3files/2016ifrsresults.pdf.
{{cite web}}: Missing/empty|title=(help) - ^ http://www.rbc.ru/companies/id/126.
{{cite web}}: Missing or empty|title=(help) - ^ Pharmstandard International
- ^ Anatoly, Zhuplev (2014). Geo-Regional Competitiveness in Central and Eastern Europe, the Baltic Countries. And Russia. IGI Global. p. 228. ISBN 9781466660557.
- ^ Spikes, Salamander Davoudiand Sarah (5 May 2007). "Russian drug IPO raises $880m". Financial Times. Retrieved 25 September 2017.
- ^ "Russia's Abramovich sells his stake in drug maker". Reuters. 2008. Retrieved 25 September 2017.
- ^ "Pharmstandard to buy ingredient supplier for $590 million". Reuters. 2013. Retrieved 25 September 2017.
- ^ "BRIEF-Pharmstandard shares to be, delisted as of March 24 - Moscow Exchange". Reuters. 17 February 2017. Retrieved 23 April 2017.
- ^ "ΠΠ± ΠΈΡΠΊΠ»ΡΡΠ΅Π½ΠΈΠΈ ΡΠ΅Π½Π½ΡΡ Π±ΡΠΌΠ°Π³ ΠΈΠ· Π‘ΠΏΠΈΡΠΊΠ° ΡΠ΅Π½Π½ΡΡ Π±ΡΠΌΠ°Π³, Π΄ΠΎΠΏΡΡΠ΅Π½Π½ΡΡ ΠΊ ΡΠΎΡΠ³Π°ΠΌ, ΠΈ ΠΎ ΠΏΡΠ΅ΠΊΡΠ°ΡΠ΅Π½ΠΈΠΈ ΡΠΎΡΠ³ΠΎΠ² ΡΠ΅Π½Π½ΡΠΌΠΈ Π±ΡΠΌΠ°Π³Π°ΠΌΠΈ". ΠΠΎΡΠΊΠΎΠ²ΡΠΊΠ°Ρ ΠΠΈΡΠΆΠ°. Retrieved 28 August 2017.